Accretion Pharmaceuticals launched its IPO on May 14, aiming to raise Rs 29.75 crore through a fresh issue of shares, with the IPO closing on May 16. The Gujarat-based company, which manufactures a range of healthcare products, plans to use the funds for capital expenditure, debt repayment, and working capital.
Global Market Today: Asian stocks waver as oil gains fuel inflation, rate concerns
Government bonds in Japan, Australia and New Zealand retreated, following declines in Treasuries during the New York session. Weak demand at a $70 billion sale